Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

CSL Limited CSLLY OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score
77/100
6/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$307.00
+1139.4%

CSLLY Insider Ownership

Top Holder
-
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value

No ownership data available for CSLLY.

People Also View

NONOF
NONOF
Novo Nordisk A/S
$38.82
+1.93%
 CMXHF
CMXHF
CSL Limited
$96.42
-2.05%
 RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
 BGNE
BGNE
BeiGene, Ltd.
$184.71
+0.49%
 CERE
CERE
Cerevel Therapeutics Holdings, Inc.
$44.96
+0.74%
 NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
 COGT
COGT
Cogent Biosciences, Inc.
$36.49
-0.08%
 KNSA
KNSA
Kiniksa Pharmaceuticals, Ltd.
$46.92
-0.80%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message